Allergan (AGN)
Add to Watchlists Create an Alert
97.71
-0.83 -0.84%
NYSE
May 22, 4:59PM
BATS Real time
Currency in USD
Allergan Cash from Investing Quarterly
Allergan Historical Cash from Investing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -377.90M |
| Sept. 30, 2012 | -19.50M |
| June 30, 2012 | 5.60M |
| March 31, 2012 | -197.50M |
| Dec. 31, 2011 | -161.90M |
| Sept. 30, 2011 | 111.10M |
| June 30, 2011 | -87.60M |
| March 31, 2011 | 479.20M |
| Dec. 31, 2010 | -327.40M |
| Sept. 30, 2010 | -547.70M |
| June 30, 2010 | -21.30M |
| March 31, 2010 | -80.80M |
| Dec. 31, 2009 | -53.20M |
| Sept. 30, 2009 | -12.30M |
| June 30, 2009 | -12.80M |
| March 31, 2009 | -20.40M |
| Dec. 31, 2008 | -87.60M |
| Sept. 30, 2008 | -222.30M |
| June 30, 2008 | -117.70M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Cash From Investing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More
AGN Cash from Investing Quarterly Benchmarks
| Companies | |
|---|---|
| Valeant Pharmaceuticals International | -234.90M |
| Solta Medical | -4.924M |
| Teva Pharmaceutical Industries | -266.00M |
AGN Cash from Investing Quarterly Range, Past 5 Years
| Minimum | -547.70M | Sep 2010 |
| Maximum | 479.20M | Mar 2011 |
| Average | -92.21M |
